GlassScriptPhysician profile
Natasha B Singh
NPI 1992069603
$1,232.97
in general payments reported to CMS, 2019-2025
13 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $167 · 2021: $168 · 2023: $153 · 2024: $321 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $306.84 | 2023-2025 | Torcon Nb, Rosen, Performer |
| Coopersurgical, INC. | $246.38 | 2020-2025 | Endosee |
| Abbvie INC. | $241.03 | 2019-2021 | |
| Edwards Lifesciences Corporation | $170.96 | 2024 | |
| Novo Nordisk INC | $72.68 | 2024 | Wegovy |
| Agile Therapeutics, INC. | $56.87 | 2021 | |
| Evofem Biosciences, INC. | $24.37 | 2021 | |
| Daiichi Sankyo INC. | $22.27 | 2019 | |
| Pfizer INC. | $21.49 | 2024 | |
| Astellas Pharma US INC | $20.47 | 2025 | Veozah |
| Amag Pharmaceuticals, INC. | $20.15 | 2020 | |
| Hologic Sales and Service, LLC | $14.87 | 2019 | |
| Allergan, INC. | $14.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natasha Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.